1988
DOI: 10.1016/s0022-3468(88)80343-9
|View full text |Cite
|
Sign up to set email alerts
|

Effective thrombolytic therapy of aortic thrombosis in the small premature infant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0
1

Year Published

1992
1992
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 8 publications
0
18
0
1
Order By: Relevance
“…Therapeutic modalities for acute bdominal aortic occlusion are embolectomy, aortobifemoral bypass, thrombolytic treatment, and axillo-bifemoral extraanatomic bypass procedures. In spite of publications that advocate thrombolytic treatment [ 11 ], we think that it may be more useful for AAO developing in the setting of a hypercoagulable state such as oral contraceptive use or factor V Leiden mutation. Treatment of AAO may vary according to the underlying etiology.…”
Section: Discussionmentioning
confidence: 92%
“…Therapeutic modalities for acute bdominal aortic occlusion are embolectomy, aortobifemoral bypass, thrombolytic treatment, and axillo-bifemoral extraanatomic bypass procedures. In spite of publications that advocate thrombolytic treatment [ 11 ], we think that it may be more useful for AAO developing in the setting of a hypercoagulable state such as oral contraceptive use or factor V Leiden mutation. Treatment of AAO may vary according to the underlying etiology.…”
Section: Discussionmentioning
confidence: 92%
“…We acknowledge that this repair was challenging and not without flaw. Richardson et al 8 described a case series of infants diagnosed with aortoiliac thromboses after UAC. In this series, all infants were treated with local infusion of intra-arterial streptokinase for 36 hours to dissolve the clot.…”
Section: Discussionmentioning
confidence: 99%
“…(32) A smaller dose of 50 U/kg per hour administered directly into the clot was effective in nine preterm infants who had aortoiliac thrombosis related to indwelling umbilical artery catheters. (33) UROKINASE. Urokinase, produced from primary cultures of kidney cells harvested postmortem from human neonates, has not been available in the United States since 1999, when the United States Food and Drug Administration issued a warning about manufacturing practices that had the potential risk for transmission of infectious agents.…”
Section: Thrombolytic Agentsmentioning
confidence: 99%